Inactive Instrument

GenMark Diagnostics, Inc.

Equities

GNMK

US3723091043

Advanced Medical Equipment & Technology

GenMark Diagnostics, Inc. Provides Preliminary Financial Results for the Fourth Quarter and Year Ended December 31, 2017

January 09, 2018 at 05:35 pm IST

GenMark Diagnostics, Inc. provided preliminary financial results for the fourth quarter and year ended December 31, 2017. Total revenue for 2017 expected to be approximately $52.5 million, representing an increase of 7% over 2016. Total revenue for the fourth quarter of 2017 expected to be approximately $16.0 million, representing an increase of 8% over the fourth quarter of 2016.

Latest news about GenMark Diagnostics, Inc.

GenMark Diagnostics, Inc. Announces Executive Changes	22/21/22	CI
Roche : Secures 83% Acceptances In $1.8 Billion Tender Offer For GenMark Diagnostics	22/21/22	MT
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P Global BMI Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P TMI Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from S&P Healthcare Equipment Select Industry Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000 Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Growth Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Small Cap Completeness Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Small Cap Comp Growth Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000 Growth Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Growth Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Microcap Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000E Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 3000E Growth Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell Microcap Growth Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Dynamic Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Dynamic Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2000 Growth-Dynamic Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from Russell 2500 Growth-Dynamic Index	22/21/22	CI
GenMark Diagnostics, Inc.(NasdaqGM:GNMK) dropped from NASDAQ Composite Index	22/21/22	CI
Roche Holding AG completed the acquisition of GenMark Diagnostics, Inc..	21/21/21	CI
Insider Trends: GenMark Diagnostics Insider Exercises Options Extending 90-Day Buying Trend	17/21/17	MT
Roche : U.S. lab products provider Avantor to buy Germany's Ritter for $1.1 bln	12/21/12	RE

Chart GenMark Diagnostics, Inc.

Duration

Period

More charts

Company Profile

GenMark Diagnostics, Inc. is a molecular diagnostics company. The Company is focused on developing and commercializing multiplex molecular tests that aid in the diagnosis of complex medical conditions. It develops and commercializes multiplex molecular tests based on its eSensor electrochemical detection technology. It offers four Food and Drug Administration (FDA)-cleared diagnostic tests which run on its XT-8 instrument; its Respiratory Viral Panel; its Cystic Fibrosis Genotyping Test; its Warfarin Sensitivity Test, and its Thrombophilia Risk Test. It also offers a Hepatitis C (HCV) genotyping test and associated custom manufactured reagents, as well as a 2C19 Genotyping Test, versions of which are available for use with its XT-8 instrument for research use only (RUO). Its XT-8 and ePlex test cartridges utilize the combination of distinct electrodes and multiple signal probes to detect dozens of target biomarkers from a single sample, thereby enabling highly multiplexed testing.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+4.46%	21TCr
DANAHER CORPORATION	+9.04%	19TCr
INTUITIVE SURGICAL, INC.	+27.99%	16TCr
BOSTON SCIENTIFIC CORPORATION	+34.03%	11TCr
SIEMENS HEALTHINEERS AG	+2.21%	6.55TCr
EDWARDS LIFESCIENCES CORPORATION	+14.40%	5.29TCr
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-6.47%	4.53TCr
AGILENT TECHNOLOGIES, INC.	-3.39%	3.97TCr
GE HEALTHCARE TECHNOLOGIES INC.	+6.65%	3.77TCr

Other Advanced Medical Equipment & Technology